Interview with Damian Marron regarding the acquisition of CAN10 IL1RAP immunology program by Otsuka Pharmaceutical
Watch the interview hereInterim CEO Damian Marron presents at Redeye Investor Forum, Stockholm
Watch the presentation hereInterview with Interim CEO Damian Marron during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
Watch the interview here(R) = Regulatory press releases